Today's regulatory sweep returned no drug approval or safety communication specific to older-adult care. That is the usual and expected result for this desk, and it reflects a structural gap rather than a quiet day: what actually governs geriatric practice is deprescribing guidance, mental capacity law, age-friendly service standards and long-term care regulation, none of which appear in drug-regulator feeds.
The substantive publication is an evidence review of nurse-led case management for community-dwelling older adults with frailty or functional impairment risk, pooling 15 randomised trials and 7,995 participants against usual care. The findings are honest and sobering. Evidence for institutionalisation, hospital admission and mortality was of very low certainty, with pooled estimates indicating little to no difference. Nurse-led case management probably produces a slight improvement in the physical component of quality of life (standardised mean difference 0.08, 95% CI 0.00-0.15, moderate certainty), and probably little to no difference in physical function.
That matters because nurse-led case management is widely commissioned on the assumption that it reduces admissions and institutionalisation, and after fifteen trials there is very low certainty that it does either. The authors' recommendation follows: evaluate these services on patient-reported outcomes alongside utilisation, rather than on utilisation alone, because utilisation is where the evidence is weakest.
- No older-adult drug approval or safety action in today's sweep
- Very low certainty evidence for institutionalisation, admissions and mortality
- Slight improvement in physical quality of life (SMD 0.08), moderate certainty
- Commission and evaluate on patient-reported outcomes, not utilisation alone
The statistics, in plain English
A standardised mean difference of 0.08 is very small — around 0.2 is conventionally the threshold for a small effect — and its interval touches zero at the lower end, so even the one positive finding is marginal. 'Very low certainty' in GRADE means the true effect is likely to be substantially different from the estimate, so the null findings on admissions and mortality should be read as unknown rather than as demonstrated absence of benefit.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for geriatrics, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free